Tag: Cancer: Ovarian
ART Treatment Not Tied to Higher Risk for Ovarian Cancer
Increased risk compared with general population likely due to nulliparity among ART-treated women; risk not increased versus subfertile women
Positive BRCA Test Results Down From 2008 to 2018
Socioeconomic and regional disparities persist in the use of BRCA testing
Women Can Conceive After Surgery for Borderline Ovarian Tumors
Fertility maintained for women undergoing fertility-sparing surgery for borderline tumors
Factors Tied to Hormone Therapy Use After Oophorectomy ID’d
Age, education, preventive mastectomy linked to hormone therapy use in BRCA mutation carriers
Most Gynecologic Cancer Therapy Not Tied to Higher COVID-19 Risk
Only recent immunotherapy use linked to death due to COVID-19 in gynecologic oncology patients
J&J Ordered to Pay $2.1 Billion in Talcum Product Lawsuit
Decision reduced by more than half the record award of $4.7 billion made to the women in July 2018
ASCO: At-Home Ovarian, Breast Cancer Genetic Testing Feasible
Testing without the traditional office visits and counseling poses no additional stress to women
Sales of Johnson’s Baby Powder Halted in U.S., Canada
Johnson & Johnson says talc-based powder is safe and will still be sold in other countries
Use of Powder in Genital Area Not Linked to Ovarian Cancer
Frequent versus never use, long-term versus never use not significantly associated with higher risk
Addition of Maintenance Olaparib Slows Advanced Ovarian Cancer
Benefit substantial for homologous-recombination deficiency positive tumors with, without BRCA mutations
